We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Two Tests and Timing Are Important in Q Fever Diagnosis

By LabMedica International staff writers
Posted on 04 Oct 2010
The diagnosis of Q fever requires both an immunoassay and a molecular test to establish a definitive diagnosis and is temporally dependent. More...


Q fever is a zoonotic disease caused by Coxiella burnetii, a species of bacteria that is distributed globally. A diagnosis of Q fever requires serologic testing to detect the presence of antibodies to C. burnetii antigens. In most laboratories, the indirect immunofluorescence assay (IFA) is the most dependable and widely used method.

In a recent study carried out at the University Hospital (Jena, Germany), the serum of 22 patients with acute Q fever, was tested by three different methods fever in reference to the time of serum collection. The serum were tested with a commercially available enzyme-linked immunosorbent assay (ELISA) called BEP III, (Virion-Serion, Wuerzburg, Germany); an indirect fluorescent antibody test (IFAT) (Focus Diagnostics, Cypress, CA, USA). An in-house nested polymerase chain reaction (PCR) was used to amplify the DNA of the organism.

A sensitivity of 30% by ELISA and 80% by IFAT) was found for the first five days of illness and 92% by ELISA and 83% by IFAT during the sixth and eleventh day. PCR revealed a positive result in eight cases (36%) with six cases deriving from the first five days of illness. The authors concluded that ELISA aids especially in the diagnosis of Q fever after five days of illness. The benefit of PCR as an additional tool to ELISA was especially evident in the early days of serum sampling. The detection rate with IFAT within the first five days was higher than the data previously reported, where 50% of the serum samples had Immunoglobulin M (IgM)-positive IFAT titers on day six. A diagnosis with IgM-IFAT could be made in 53% (17/32) of patients during the first week after onset, and in 89% (33/37) during the second week. The results of the study were published in the October 2010, issue of Diagnostic Microbiology and Infectious Disease.

Outbreaks of Q fever are often associated with sheep and goat farms and a large outbreak has been ongoing in the Netherlands since 2007. There have also been recent outbreaks in the UK and Germany, as well as amongst US marines stationed in Iraq.

Related Links:

University Hospital
Virion-Serion
Focus Diagnostics




New
Gold Member
Hematology Analyzer
Medonic M32B
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Hemodynamic System Monitor
OptoMonitor
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The VeraBIND Tau assay is a novel blood test that identifies the presence of active tau pathology (Photo courtesy of 123RF)

First Blood-Based Test Measures Key Alzheimer's Biomarker in Asymptomatic and Symptomatic Individuals

Alzheimer’s disease (AD), the sixth leading cause of death in the United States, affects an estimated 7.2 million Americans aged 65 or older. Current diagnostic methods for AD are often invasive, expensive,... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.